Earlier this month Oracle closed its $28.3B acquisition of Cerner and shortly after Oracle founder and CTO, Larry Ellison, outlined Oracle’s vision for Healthcare IT post-acquisition. The key elements of this vision included: - Developing a solution for a national EHR database. - Leveraging this solution, and similar smaller-scale connected EHR initiatives, to provide life science, pharma and other users with a rich environment for research, clinical trials and drug
Read More
Alex Green, Director at Signify Research
Alex Green is the Director and Principal Analyst at Signify Research, a UK-based market research firm focusing on health IT, digital health, and medical imaging. Alex is responsible for leading Signify Research’s Digital Health market intelligence portfolio, initially developing its coverage of the patient engagement platforms and portals market
Post-COVID Telehealth in Europe: What Works for Primary Care? – Analysis
The European primary care telehealth market has been transformed since the outbreak of COVID-19 more than 15 months ago. But which countries have developed an ecosystem that is primed for long-term growth that will bring value and improved processes to both healthcare providers and patients? A key starting point is to define the vendors that serve primary care telehealth. There are two types of company that address this market. - Telehealth Service Providers – These are companies that sell
Read More
Dedalus Completes Acquisition of DXC’s Provider Healthcare Business – M&A Analysis
What You Should Know: Last week saw Dedalus complete the purchase of DXC’s healthcare provider business for $450M, a deal that was originally announced in July 2020. - DXC was created in 2017 via the merger of CSC and the Enterprise Services business of Hewlett Packard Enterprise (HPE) - Dedalus has been through a rapid acquisition program over the last ten years acquiring a majority position with France-based Medasys/Noemalife in 2016 and then acquiring the EHR and integrated care
Read More
AmWell IPO and Google Deal – Five Key Takeaways to Know
1) COVID-19 Has Driven Revenue Up 77% The headline revenue data (summarised below) provides very positive news for AmWell and its new investor, Google. Notably: - Even prior to COVID-19, the company was growing well with revenues increasing by 31% in 2019 compared to 2018. - This rate of growth has accelerated in 1H20, with overall revenue up 77% in the same period in 2019. - The 2019 growth was partly driven by a small increase in the number of health plan subscription customers and
Read More
COVID-19 and Its Global Impact on Primary Care Virtual Consultations
Last week saw Teladoc Health release its 1Q20 financial results giving the US telehealth industry a first glimpse of how COVID-19 is impacting the ambulatory virtual care market. Discussion around the crisis and its impact on telehealth has been rife since early March and the data published by Teladoc Health highlights that this was justified. The company reported that the number of virtual care consults in the quarter had passed the 2 million mark, up approximately 60% from the 1.24M
Read More
Dedalus to Acquire Agfa’s HCIS Business: Impact on European EMR Market
Yesterday Agfa announced it had entered exclusive negotiations with Dedalus Holding to sell part of its Healthcare IT business, specifically the business tied to its EMR and Integrated Care offerings. The facts are:- In May 2019 Agfa stated it would explore selling its Hospital IT and Integrated Care (HCIS) solutions business.- This process was brought a step forward towards the conclusion yesterday with the announcement that the deal (valued at €945M) would be completed during Q2 2020, and
Read More
Health Catalyst IPO Journey: Future Opportunities & Challenges to Watch
Last week saw Health Catalyst common stock begin trading on the Nasdaq Global Select Market. This marks the culmination of a journey that started 11 years ago and provides a great illustration of a start-up that has maximized the potential of the move in healthcare to value-based care. However, the IPO comes at a time where there is some uncertainty gripping the markets it targets and there are several key challenges for Health Catalyst to overcome in order to drive future success. Here’s our
Read More
Analysis: Cerner, Epic, Allscripts and MEDITECH’s International EHR Endeavours
In this insight, we assess how the top US acute EHR vendors, namely Epic, Cerner, Allscripts and MEDITECH (+85% share of US acute market in terms of revenues), have progressed specifically on the third point, international expansion.The below figure shows that there is a significant variance amongst the big four in terms of revenue and share of business outside the US. Cerner has by far the highest revenue at more than $600M in 2018, representing 12% of its business. Whilst MEDITECH has much
Read More
Analysis: Examining The Highly Fragmented International EHR Market
The EMEA market for EMR/EHR IT is estimated to have been worth $3.7B in 2018 (both acute and ambulatory applications) according to Signify Research’s recently published market report on the global EMR/EHR market. However, only one vendor, Cerner, is estimated to have had a double-digit revenue share. Despite its recent announcement that it will potentially sell its Hospital IT and Integrated Care business, Agfa Health was the only other vendor to come close. In terms of suppliers, the market is
Read More
Healthcare M&A: Agfa to Consider Selling Health IT & Integrated Care Business
Last week Agfa announced its Board of Directors would investigate the sale of part of Agfa HealthCare, specifically, the business tied to its EMR and integrated care offerings. The facts are:· In March 2019, Agfa initially stated that it would further extend the independence of Agfa HealthCare.· It has now expanded on what this could potentially look like, stating it will explore selling is Hospital IT and Integrated Care solutions.· In terms of its reportable business this is largely the
Read More
